|
US4258051A
(en)
*
|
1975-01-10 |
1981-03-24 |
Research Corporation |
Method of treating viral infections
|
|
JPS6041077B2
(ja)
*
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
１，２‐ジアミノシクロヘキサン異性体のシス白金（２）錯体
|
|
US4440782A
(en)
*
|
1977-03-01 |
1984-04-03 |
Research Corporation |
Method of treating viral infections
|
|
SE447902B
(sv)
*
|
1977-10-19 |
1986-12-22 |
Johnson Matthey Co Ltd |
Cis-koordinationsforening av platina och komposition innehallande foreningen
|
|
SE447385B
(sv)
*
|
1977-10-19 |
1986-11-10 |
Johnson Matthey Co Ltd |
Cis-koordinationsforeningar av platina
|
|
DE2845371A1
(de)
*
|
1977-10-19 |
1979-04-26 |
Johnson Matthey Co Ltd |
Platinkomplexverbindung, pharmazeutische stoffzusammensetzung mit einer solchen verbindung und deren anwendung
|
|
SE7903359L
(sv)
*
|
1978-04-20 |
1979-10-21 |
Johnson Matthey Co Ltd |
Kompositioner innehallande platina
|
|
SE7903360L
(sv)
*
|
1978-04-20 |
1979-10-21 |
Johnson Matthey Co Ltd |
Kompositioner innehallande platina
|
|
SE7903361L
(sv)
*
|
1978-04-20 |
1979-10-21 |
Johnson Matthey Co Ltd |
Kompositioner innehallande platina
|
|
NL7807334A
(nl)
*
|
1978-07-06 |
1980-01-08 |
Tno |
Platina-diaminecomplexen, werkwijze voor het bereiden daarvan, werkwijze voor het bereiden van een genees- middel met toepassing van een dergelijk platina-dia- minecomplex voor de behandeling van kanker, alsmede al- dus verkregen gevormd geneesmiddel.
|
|
JPS6034958B2
(ja)
*
|
1978-09-02 |
1985-08-12 |
喜徳 喜谷 |
新規白金錯体
|
|
US4234500A
(en)
*
|
1979-03-07 |
1980-11-18 |
Engelhard Minerals & Chemicals Corporation |
Ethylenediamine platinum(II) and 1,2-diamino-cyclohexane platinum(II) pyrophosphate complexes
|
|
US4291027A
(en)
*
|
1979-03-07 |
1981-09-22 |
Engelhard Minerals & Chemicals Corp. |
Method for treating tumors with ethylenediamine platinum (II) and 1,2-diaminocyclohexane-platinum (II) pyrophosphate complexes
|
|
US4462998A
(en)
*
|
1979-06-20 |
1984-07-31 |
Engelhard Corporation |
Method of using a cis-platinum(II) amine ascorbate
|
|
US4505928A
(en)
*
|
1979-06-20 |
1985-03-19 |
Engelhard Corporation |
Pharmaceutical composition containing cis-platinum (II) amine lactate and a method of using same
|
|
US4457926A
(en)
*
|
1979-06-20 |
1984-07-03 |
Engelhard Corporation |
Cis-Platinum(II) amine ascorbate complexes
|
|
US4271085A
(en)
*
|
1979-06-20 |
1981-06-02 |
Engelhard Minerals & Chemicals Corporation |
Cis-platinum (II) amine lactate complexes
|
|
US4284579A
(en)
*
|
1979-07-17 |
1981-08-18 |
The United States Of America As Represented By The Of The Department Of Health & Human Services |
(N-Phosphonacetyl-L-aspartato)(1,2-diaminocyclchexane)platinum(II) or alkali metal salt
|
|
ZA805101B
(en)
*
|
1979-08-23 |
1981-08-26 |
Johnson Matthey Co Ltd |
Compositions containing platinium
|
|
NL181434C
(nl)
*
|
1980-01-03 |
1987-08-17 |
Tno |
Platina(iv)-diamine-complexen, alsmede hun bereiding en toepassing.
|
|
GR75598B
(US20080094685A1-20080424-C00004.png)
*
|
1980-04-29 |
1984-08-01 |
Sanofi Sa |
|
|
JPS56154493A
(en)
*
|
1980-04-30 |
1981-11-30 |
Shionogi & Co Ltd |
Novel platinum complex
|
|
AU538863B2
(en)
*
|
1980-05-27 |
1984-08-30 |
Bristol-Myers Company |
Platinum complex salts have anti-tumor property
|
|
US4322362A
(en)
*
|
1980-07-28 |
1982-03-30 |
Bristol-Myers Company |
Salts of 2-hydroxymalonate platinum complexes
|
|
US4428943A
(en)
|
1980-06-09 |
1984-01-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
(N-Phosphonacetyl-L-aspartato) (1,2-diaminocyclohexane)platinum(II) or alkali metal salt
|
|
JPS5851959B2
(ja)
*
|
1980-06-11 |
1983-11-19 |
呉羽化学工業株式会社 |
プラチナ化合物とその医薬組成物
|
|
JPS5716895A
(en)
*
|
1980-07-05 |
1982-01-28 |
Otsuka Chem Co Ltd |
Platinum 2 complex and antitumor agent containing the same as active principle
|
|
JPS57123198A
(en)
*
|
1981-01-23 |
1982-07-31 |
Shionogi & Co Ltd |
Novel platinum complex
|
|
JPS5896024A
(ja)
*
|
1981-10-16 |
1983-06-07 |
リチヤ−ド・エフ・ストツケル |
白金毒解毒剤
|
|
US4500465A
(en)
*
|
1982-06-28 |
1985-02-19 |
Engelhard Corporation |
Solubilized platinum (II) complexes
|
|
US4584392A
(en)
*
|
1982-11-10 |
1986-04-22 |
Inco Alloys International, Inc. |
Platinum and palladium complexes
|
|
US4560782A
(en)
*
|
1982-11-19 |
1985-12-24 |
Research Corporation |
Anti-tumor diplatinum coordination compounds
|
|
IL67789A
(en)
*
|
1983-01-31 |
1986-09-30 |
Yissum Res Dev Co |
Amino-substituted malonato platinum(ii)complexes and method for their preparation
|
|
US4533502A
(en)
*
|
1983-02-22 |
1985-08-06 |
Rochon Fernande D |
Platinum (II) compounds and their preparation
|
|
US4906646A
(en)
*
|
1983-03-31 |
1990-03-06 |
Board Of Governors Of Wayne State University |
Method and composition for the treatment of tumors by administering a platinum coordination compound and a calcium channel blocker compound of the dihydropyridine class
|
|
US4617189A
(en)
*
|
1983-04-14 |
1986-10-14 |
Stockel Richard F |
Use of selenium-containing compounds for negating the toxic effects of platinum compounds used in chemotherapy, and a novel selenium-containing platinum compound and use thereof as an anti-cancer medicine
|
|
JPS59222498A
(ja)
*
|
1983-06-01 |
1984-12-14 |
Shionogi & Co Ltd |
新規グリコ−ル酸系白金錯体および抗悪性腫瘍剤
|
|
DK301684A
(da)
*
|
1983-06-20 |
1984-12-21 |
Research Corp |
Diaminocyklohexanplatinkomplekser
|
|
US4661516A
(en)
*
|
1983-06-20 |
1987-04-28 |
Research Corporation |
Diaminocyclohexane platinum complexes
|
|
US4758588A
(en)
*
|
1983-06-20 |
1988-07-19 |
Research Corporation Technologies |
Diaminocyclohexane platinum complexes
|
|
EP0136012B1
(en)
*
|
1983-08-05 |
1989-04-19 |
Yoshinori Kidani |
Cytostatic platinum complexes
|
|
GB8328218D0
(en)
*
|
1983-10-21 |
1983-11-23 |
Johnson Matthey Plc |
Oral compositions
|
|
DE3490640C2
(de)
*
|
1984-01-23 |
1990-04-19 |
Inst Obschei I Neoorganichesko |
Platin (II)-Carboxylatokomplexe und Verfahren zu ihrer Herstellung
|
|
US4843161A
(en)
*
|
1984-06-01 |
1989-06-27 |
Massachusetts Institute Of Technology |
Platinum-intercalative complexes for the treatment of cancer
|
|
GB8416048D0
(en)
*
|
1984-06-22 |
1984-07-25 |
Johnson Matthey Plc |
Anti-tumour compounds of platinum
|
|
EP0169645A1
(en)
*
|
1984-06-27 |
1986-01-29 |
Johnson Matthey Public Limited Company |
Platinum co-ordination compounds
|
|
US4645661A
(en)
*
|
1984-06-29 |
1987-02-24 |
St. Jude Children's Research Hospital |
Method for alleviating cisplatin-induced nephrotoxicity and dithiocarbamate compounds for effecting same
|
|
IL76889A0
(en)
*
|
1984-11-02 |
1986-02-28 |
Johnson Matthey Plc |
Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
|
|
US4588831A
(en)
*
|
1984-11-09 |
1986-05-13 |
Natec |
Platinum complex compounds of substituted 5,8-dihydroxyl-1,4-naphthoquinone, and process for their production and use
|
|
US4665210A
(en)
*
|
1984-12-17 |
1987-05-12 |
American Cyanamid Company |
Platinum complexes of aliphatic tricarboxylic acids
|
|
ZA86704B
(en)
*
|
1985-02-23 |
1986-10-29 |
Asta Werke Ag Chem Fab |
Tumor retarding(1-benzyl-ethylenediamine9-platin(ii)-complexes
|
|
CA1274529A
(en)
*
|
1985-09-05 |
1990-09-25 |
Federico Sampedro |
Platinum(ii) complexes of 1,1-cyclobutane- dicarboxylate and process for their production
|
|
US4658047A
(en)
*
|
1985-09-27 |
1987-04-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Method of preparing 1,2-diaminocyclohexane tetrachloro platinum (IV) isomers
|
|
US5041581A
(en)
*
|
1985-10-18 |
1991-08-20 |
The University Of Texas System Board Of Regents |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US5384127A
(en)
*
|
1985-10-18 |
1995-01-24 |
Board Of Regents, The University Of Texas System |
Stable liposomal formulations of lipophilic platinum compounds
|
|
US5117022A
(en)
*
|
1985-10-18 |
1992-05-26 |
The Board Of Regents, The University Of Texas System |
Hydrophobic cis-platinum complexes efficiently incorporated into liposomes
|
|
US4760157A
(en)
*
|
1986-01-31 |
1988-07-26 |
American Cyanamid Company |
(2,2,-bis(aminomethyl)-1,3-propanediol-N,N')platinum complexes
|
|
US4670458A
(en)
*
|
1986-01-31 |
1987-06-02 |
American Cyanamid Company |
Hydroxylated 1,2-diaminocyclohexane platinum complexes
|
|
CS269719B1
(en)
*
|
1986-12-29 |
1990-05-14 |
Kiss Frantisek |
Platinum cytostatic
|
|
US5393909A
(en)
*
|
1988-11-22 |
1995-02-28 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
|
US5434256A
(en)
*
|
1988-11-22 |
1995-07-18 |
Board Of Regents, The University Of Texas System |
Diamine platinum complexes as antitumor agents
|
|
US5041578A
(en)
*
|
1988-11-22 |
1991-08-20 |
Board Of Regents, The University Of Texas System |
Water soluble 1,2-diaminocyclohexane platinum (IV) complexes as antitumor agents
|
|
US6884418B1
(en)
*
|
1989-08-04 |
2005-04-26 |
Berlex Laboratories, Inc. |
Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
|
|
US5455270A
(en)
*
|
1993-08-11 |
1995-10-03 |
Bristol-Myers Squibb Co. |
Stabilized solutions of platinum(II) antitumor agents
|
|
ES2160117T3
(es)
*
|
1994-02-07 |
2001-11-01 |
Pliva Pharmaceutical Industry |
Composicion farmaceutica antitumoral a base de carboplatino, y su procedimiento de produccion.
|
|
US5922689A
(en)
*
|
1995-09-11 |
1999-07-13 |
Unitech Pharmaceuticals, Inc. |
Cisplatin analogs for cancer treatment
|
|
JP3154399B2
(ja)
*
|
1996-07-04 |
2001-04-09 |
デビオファーム エス．アー． |
白金化合物の製造方法
|
|
US20040072889A1
(en)
*
|
1997-04-21 |
2004-04-15 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
|
|
CN1068002C
(zh)
*
|
1997-04-30 |
2001-07-04 |
中国科学院大连化学物理研究所 |
铂抗癌药物及合成
|
|
ATE328599T1
(de)
*
|
1998-04-03 |
2006-06-15 |
Ajinomoto Kk |
Antitumorale mittel
|
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
|
EP2266607A3
(en)
|
1999-10-01 |
2011-04-20 |
Immunogen, Inc. |
Immunoconjugates for treating cancer
|
|
WO2001036431A1
(en)
|
1999-11-15 |
2001-05-25 |
Parker Hughes Institute |
Diamino platinum (ii) antitumor complexes
|
|
US6545010B2
(en)
*
|
2000-03-17 |
2003-04-08 |
Aventis Pharma S.A. |
Composition comprising camptothecin or a camptothecin derivative and a platin derivative for the treatment of cancer
|
|
ATE359823T1
(de)
*
|
2000-06-30 |
2007-05-15 |
Lilly Co Eli |
Zusammensetzung, welche ein antifolate und ein methylmalonsäuresenkendes mittel enthält
|
|
DE10032256C2
(de)
*
|
2000-07-03 |
2003-06-05 |
Infineon Technologies Ag |
Chip-ID-Register-Anordnung
|
|
TWI315982B
(en)
|
2001-07-19 |
2009-10-21 |
Novartis Ag |
Combinations comprising epothilones and pharmaceutical uses thereof
|
|
US20040191218A1
(en)
*
|
2001-09-26 |
2004-09-30 |
Emlen James W |
Pharmaceutical compositions and methods for treating cancer
|
|
US7038071B2
(en)
*
|
2002-07-16 |
2006-05-02 |
Sonus Pharmaceuticals, Inc. |
Platinum compounds
|
|
US7160908B2
(en)
*
|
2003-03-04 |
2007-01-09 |
Unitech Pharmaceuticals, Inc. |
Dynamic anticancer platinum compounds
|
|
CA2560059A1
(en)
*
|
2004-03-15 |
2005-09-29 |
Sonus Pharmaceuticals, Inc. |
Platinum carboxylate anticancer compounds
|
|
MX2007008810A
(es)
|
2005-01-21 |
2007-11-21 |
Astex Therapeutics Ltd |
Compuestos farmaceuticos.
|
|
WO2006103691A1
(en)
*
|
2005-03-28 |
2006-10-05 |
Dabur Pharma Ltd. |
Stable pharmaceutical compositions of platinum (ii) antitumour agents
|
|
US20090317489A1
(en)
|
2006-05-09 |
2009-12-24 |
Hanspeter Nick |
Combination Comprising an Iron Chelator and an Anti-Neoplastic Agent and Use Thereof
|
|
WO2008044041A1
(en)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
EP2073807A1
(en)
|
2006-10-12 |
2009-07-01 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
CA2667019C
(en)
|
2006-10-27 |
2016-03-29 |
Genentech, Inc. |
Antibodies and immunoconjugates and uses therefor
|
|
WO2009060198A1
(en)
|
2007-11-09 |
2009-05-14 |
Peregrine Pharmaceuticals, Inc. |
Anti-vegf antibody compositions and methods
|
|
TWI675668B
(zh)
|
2008-03-18 |
2019-11-01 |
美商建南德克公司 |
抗ｈｅｒ２抗體-藥物結合物及化療劑之組合及使用方法
|
|
KR20100131457A
(ko)
|
2008-03-27 |
2010-12-15 |
다이호야쿠힌고교 가부시키가이샤 |
시티딘 유도체 및 카르보플라틴을 함유하는 항종양제
|
|
JP4664424B2
(ja)
|
2008-09-03 |
2011-04-06 |
ユニーテック株式会社 |
白金錯体及びそれを含む医薬組成物
|
|
EP2407786A4
(en)
|
2009-03-12 |
2013-01-02 |
Univ Kinki |
METHOD FOR PREDICTING THE THERAPEUTIC EFFICACY OF CHEMOTHERAPY ON NON-SMALL CELL LUNG CANCER
|
|
CN103857395A
(zh)
|
2011-04-01 |
2014-06-11 |
基因泰克公司 |
Akt抑制剂化合物和阿比特龙的组合及使用方法
|
|
EP2508525A1
(en)
|
2011-04-05 |
2012-10-10 |
Bayer Pharma Aktiengesellschaft |
Substituted 2,3-dihydroimidazo[1,2-c]quinazoline salts
|
|
JP5179628B2
(ja)
|
2011-07-15 |
2013-04-10 |
ユニーテック株式会社 |
４価白金錯体及びそれを含む医薬組成物
|
|
AU2013273489B9
(en)
|
2012-06-08 |
2018-08-23 |
F. Hoffmann-La Roche Ag |
Mutant selectivity and combinations of a phosphoinositide 3 Kinase inhibitor compound and chemotherapeutic agents for the treatment of cancer
|
|
PL3386997T3
(pl)
|
2015-12-09 |
2021-12-13 |
Medizinische Universität Wien |
Funkcjonalizowane monomaleimidem związki platyny do terapii nowotworowej
|
|
WO2017192290A1
(en)
|
2016-05-04 |
2017-11-09 |
The Wistar Institute Of Anatomy And Biology |
Methods of treating cancers overexpressing carm1 with ezh2 inhibitors and platinum-based antineoplastic drugs
|
|
CN107773556B
(zh)
*
|
2016-08-26 |
2020-08-18 |
广州安好医药科技有限公司 |
一种具有抗肿瘤药物功效的联合用药物
|
|
BR112019018767A2
(pt)
|
2017-04-03 |
2020-05-05 |
Hoffmann La Roche |
anticorpos, molécula de ligação ao antígeno biespecífica, um ou mais polinucleotídeos isolados, um ou mais vetores, célula hospedeira, método para produzir um anticorpo, composição farmacêutica, usos, método para tratar uma doença em um indivíduo e invenção
|
